Headlines

Exosomes and other regenerative medicine treatments are expanding in Japan, raising safety and regulatory concerns over contamination risks...

Extracellular vesicles and exosomes are being explored for skin and hair treatments, but concerns remain about product quality, long-term safety, and lack of FDA approval...

SlovSEV brings together Slovak researchers studying extracellular vesicles to advance collaboration, diagnostics, therapeutics, education, and international participation in EV research...

Texas A&M’s nasal spray therapy uses neural stem cell-derived extracellular vesicles to reduce brain inflammation and slow Alzheimer’s-related...

In a milestone for cellular research, eMBR Genomics and Axio BioPharma announce the first commercial availability of MKLP1 Pro™ antibodies, KIF23 gene – the same tools used by the world’s leading Midbody Remnants (MBRs) researchers. This strategic partnership combines eMBR’s innovation ...

From September 17 to 19, 2024, the 6th Exosome-Based Therapeutic Development Summit will bring together global experts in the field of exosome-based therapeutics. Among the key participants is Creative Biolabs, a leading force in exosome research and development. The summit, ...

CELLDATA DNAstorm™ and RNAstorm™ 2.0 MagBead FFPE Kits for DNA and RNA extraction allow for greater streamlined automation...

Evox has been granted US Patent US11,640,272. The claims of this patent cover a method of purifying engineered exosomes via a downstream process utilizing ultrafiltration and size-based separation...

Rhode Island Hospital is enrolling for an innovative Alzheimer’s clinical trial called the ExosomeAD study. Exosomes are tiny structures found in cells throughout our body, that when looked at closely...

FIMM HiPREP offers EV Core services together with the Faculty of Biological and Environmental Sciences (Viikki campus) since 2016. We offer state-of-the-art and emerging EV technologies for research groups...